Glycodendrimers: versatile tools for nanotechnology
暂无分享,去创建一个
[1] L. BenMohamed,et al. Towards a Self‐Adjuvanting Multivalent B and T cell Epitope Containing Synthetic Glycolipopeptide Cancer Vaccine , 2008, ChemMedChem.
[2] I. García,et al. Glyconanoparticles: New Nanomaterials for Biological Applications , 2010 .
[3] J. Kovensky,et al. Clustering of Escherichia coli type-1 fimbrial adhesins by using multimeric heptyl α-D-mannoside probes with a carbohydrate core. , 2011, Chemistry.
[4] R. Roy,et al. Synthesis and antibody binding properties of glycodendrimers bearing the tumor related T-antigen , 2001 .
[5] S. Morey,et al. Development and Characterization of Monoclonal Antibody to T-Antigen: (Galβl—3GalNAc-α-O) , 1998 .
[6] R. Pieters,et al. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1. , 2013, Journal of medicinal chemistry.
[7] S. Morey,et al. Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O). , 1998, Hybridoma.
[8] R. Roy,et al. Design and Creativity in Synthesis of Multivalent Neoglycoconjugates , 2010, Advances in Carbohydrate Chemistry and Biochemistry.
[9] M. Marradi,et al. Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. , 2010, Advances in carbohydrate chemistry and biochemistry.
[10] K A Baggerly,et al. New tumor markers: CA125 and beyond , 2005, International Journal of Gynecologic Cancer.
[11] D. Kasper,et al. Coming of age: carbohydrates and immunity , 2005, European journal of immunology.
[12] R. D. De Silva,et al. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. , 2009, Journal of the American Chemical Society.
[13] R. Roy,et al. Application of Multivalent Mannosylated Dendrimers in Glycobiology , 2007, Comprehensive Glycoscience.
[14] J. Rojo,et al. Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions. , 2001, Angewandte Chemie.
[15] L. Morelli,et al. Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation , 2011 .
[16] Kheireddine El-Boubbou,et al. Glyco-nanomaterials: translating insights from the "sugar-code" to biomedical applications. , 2011, Current medicinal chemistry.
[17] G. Springer. T and Tn, general carcinoma autoantigens. , 1984, Science.
[18] Alssandra Franco. Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions. , 2008, Anti-Cancer Agents in Medicinal Chemistry.
[19] A. Almogren,et al. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy. , 2012, Frontiers in bioscience.
[20] M. Mutter,et al. A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT) , 1995 .
[21] R. Roy,et al. Expeditive synthesis of glycodendrimer scaffolds based on versatile TRIS and mannoside derivatives. , 2008, The Journal of organic chemistry.
[22] U. Nilsson,et al. Inhibition of galectins with small molecules. , 2011, Chimia.
[23] O. Finn,et al. Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.
[24] R. Roy,et al. Glycodendrimers as anti-adhesion drugs against type 1 fimbriated E. coli uropathogenic infections. , 2007, Mini reviews in medicinal chemistry.
[25] A. Imberty,et al. Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins. , 2008, Chemistry.
[26] L. BenMohamed,et al. Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes , 2009, Cancer Immunology, Immunotherapy.
[27] Chang‐Ming Dong. Glyconanoparticles for biomedical applications. , 2011, Combinatorial chemistry & high throughput screening.
[28] S. Danishefsky,et al. From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines , 2000 .
[29] R. Roy,et al. First synthesis of "Majoral-Type" glycodendrimers bearing covalently bound alpha-D-mannopyranoside residues onto a hexachlocyclotriphosphazene core. , 2008, The Journal of organic chemistry.
[30] G. Ragupathi. Carbohydrate antigens as targets for active specific immunotherapy , 1996, Cancer Immunology, Immunotherapy.
[31] J. Barchi,et al. Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. , 2008, Carbohydrate research.
[32] F. Avci,et al. How bacterial carbohydrates influence the adaptive immune system. , 2010, Annual review of immunology.
[33] J. M. de la Fuente,et al. Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. , 2006, Biochimica et biophysica acta.
[34] H. Gabius,et al. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. , 1999, Glycobiology.
[35] R. Roy,et al. Simultaneous binding of mouse monoclonal antibody and streptavidin to heterobifunctional dendritic L-lysine core bearing T-antigen tumor marker and biotin. , 2001, Bioorganic & medicinal chemistry.
[36] M. Baek,et al. Design and synthesis of water-soluble glycopolymers bearing breast tumor marker and enhanced lipophilicity for solid-phase assays. , 2000, Biomacromolecules.
[37] J. Barchi,et al. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. , 2012, Bioconjugate chemistry.
[38] R. Roy,et al. Recent trends in glycodendrimer syntheses and applications. , 2008, Current topics in medicinal chemistry.
[39] T. Lindhorst,et al. The Bacterial Lectin FimH, a Target for Drug Discovery – Carbohydrate Inhibitors of Type 1 Fimbriae‐Mediated Bacterial Adhesion , 2011 .
[40] R. Roy,et al. Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers. , 2002, Bioorganic & medicinal chemistry.
[41] H. Gabius. The sugar code : fundamentals of glycosciences , 2009 .
[42] R. Roy,et al. Dendrimer‐Coated Carbohydrate Residues as Drug Delivery Trojan Horses in Glycoscience , 2012 .
[43] J. Kovensky,et al. Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic Escherichia coli , 2009, ChemMedChem.
[44] V. Huxley,et al. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. , 2006, Neoplasia.
[45] H. Gabius,et al. Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins. , 2011, Bioorganic & medicinal chemistry.
[46] R. Roy,et al. Synthesis of N,N′-Bis(acrylamido)acetic Acid-Based T-Antigen Glycodendrimers and Their Mouse Monoclonal IgG Antibody Binding Properties. , 2001 .
[47] S. Hakomori,et al. Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.
[48] H. Gabius,et al. Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance , 2010 .
[49] R. Roy. A Decade of Glycodendrimer Chemistry , 2003 .
[50] Angela Liakatos,et al. Synthetic glycopeptides for the development of cancer vaccines. , 2007, Current opinion in molecular therapeutics (Print).
[51] A. Imberty,et al. Synthesis and Biological Applications of Glycoconjugates , 2012 .
[52] Philip S. Livingston,et al. Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines , 1995, Immunological reviews.
[53] R. Roy,et al. Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines. , 2011, Chimia.
[54] S. Svarovsky,et al. Synthesis of gold nanoparticles bearing the Thomsen–Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen , 2005 .
[55] R. Roy,et al. Applications of Glyconanoparticles as "Sweet" Glycobiological Therapeutics and Diagnostics , 2013 .
[56] R. Roy,et al. Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein. , 2002, Journal of biotechnology.
[57] G. Ragupathi,et al. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans , 1997, Cancer Immunology, Immunotherapy.
[58] G. Jung,et al. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships. , 2004, Vaccine.
[59] A. Nesburn,et al. Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity , 2010, PloS one.
[60] J. Fahy,et al. Hexaphenylbenzene as a rigid template for the straightforward syntheses of "star-shaped" glycodendrimers. , 2011, The Journal of organic chemistry.
[61] Clemens Burda,et al. The unique role of nanoparticles in nanomedicine : imaging , drug delivery and therapy , 2012 .
[62] L. Cipolla,et al. Glycoconjugates in cancer therapy. , 2008, Anti-cancer agents in medicinal chemistry.
[63] M. Tremblay,et al. Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection , 2011, Antimicrobial Agents and Chemotherapy.
[64] Sachiko Sato,et al. Synthesis of stable and selective inhibitors of human galectins-1 and -3. , 2008, Bioorganic & medicinal chemistry.
[65] K. Pienta,et al. Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. , 2012, Neoplasia.
[66] Allen,et al. From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix. , 2000, Angewandte Chemie.
[67] R. Roy. Carbohydrate-based vaccines , 2008 .
[68] S. Nishimura,et al. Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands , 2002, Chembiochem : a European journal of chemical biology.
[69] G. Boons,et al. Carbohydrate-based vaccines and immunotherapies , 2009 .
[70] O. Renaudet,et al. Synthesis of multi-antigenic platforms as vaccine candidates against cancers , 2013 .
[71] H. Kunz,et al. Synthetic vaccines from tumor-associated glycopeptide antigens. , 2011, Chimia.
[72] S. Hintermann,et al. Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[73] R. Narain,et al. Engineered carbohydrate-based materials for biomedical applications : , 2011 .
[74] H. Ananthaswamy,et al. Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs , 1996, Clinical & Experimental Metastasis.
[75] Hayyoung Lee,et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.
[76] I. García,et al. Glyconanoparticles as Multifunctional and Multimodal Carbohydrate Systems , 2013 .
[77] C. Leclerc,et al. Carbohydrate antigens: synthesis aspects and immunological applications in cancer. , 2006, Mini reviews in medicinal chemistry.
[78] S. Paik,et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.
[79] R. Roy,et al. A first QSAR model for galectin-3 glycomimetic inhibitors based on 3D docked structures. , 2006, Medicinal chemistry.
[80] A. Imberty,et al. Glycoliposomes and metallic glyconanoparticles in glycoscience , 2012 .
[81] Mathias Brust,et al. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .
[82] R. Roy,et al. Diazo transfer and click chemistry in the solid phase syntheses of lysine-based glycodendrimers as antagonists against Escherichia coli FimH. , 2012, Molecular pharmaceutics.
[83] A. Imberty,et al. Multivalent glycoconjugates as anti-pathogenic agents. , 2013, Chemical Society reviews.
[84] V. Křen,et al. Dendri-RAFTs: a second generation of cyclopeptide-based glycoclusters. , 2011, Organic & biomolecular chemistry.
[85] R. Roy,et al. Glycodendrimers as functional antigens and antitumor vaccines , 2012 .
[86] I. García,et al. Glyconanoparticles: multifunctional nanomaterials for biomedical applications. , 2010, Nanomedicine.
[87] Mingdi Yan,et al. Glyconanomaterials: Synthesis, Characterization, and Ligand Presentation , 2010, Advanced materials.
[88] R. Roy,et al. Glycodendrimer coated gold nanoparticles for proteins detection based on surface energy transfer process , 2012 .
[89] R. Roy,et al. Multivalent glycoconjugate syntheses and applications using aromatic scaffolds. , 2013, Chemical Society reviews.
[90] K. Lloyd,et al. Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale , 1997, Cancer Immunology, Immunotherapy.
[91] Sachiko Sato,et al. Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3. , 2006, Bioorganic & medicinal chemistry letters.
[92] J. Bouckaert,et al. The functional valency of dodecamannosylated fullerenes with Escherichia coli FimH--towards novel bacterial antiadhesives. , 2011, Chemical communications.
[93] E. Schmitt,et al. Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2. , 2010, Angewandte Chemie.
[94] R. P. Cheng,et al. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. , 2009, Neoplasia.
[95] M. Carmen Galan,et al. Carbohydrate Chemistry in Drug Discovery , 2011 .
[96] Zhongwu Guo,et al. Recent development in carbohydrate-based cancer vaccines. , 2009, Current opinion in chemical biology.
[97] R. Roy. New trends in carbohydrate-based vaccines. , 2004, Drug discovery today. Technologies.
[98] Yiyun Cheng,et al. Dendrimer-based drug delivery systems : from theory to practice , 2012 .
[99] S. Gendler,et al. Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.
[100] S. Hakomori,et al. Synthetic vaccines : synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins , 1994 .
[101] T. Toyokuni,et al. Synthetic carbohydrate vaccines based on tumour-associated antigens , 1996 .
[102] H. Kunz,et al. Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy. , 2006, Current cancer drug targets.
[103] R. Roy,et al. Carbohydrate-coated lanthanide-doped upconverting nanoparticles for lectin recognition , 2010 .
[104] R. Narain. Engineered carbohydrate-based materials for biomedical applications : polymers, surfaces, dendrimers, nanoparticles, and hydrogels , 2011 .
[105] I. García,et al. Carbohydrate-based nanoparticles for potential applications in medicine. , 2011, Progress in molecular biology and translational science.